CHICAGO – The former American Association of Diabetes Educators is now the Association of Diabetes Care & Education Specialists (ADCES). The rebranding reflects the association’s shift from referencing the specialty title as “diabetes educator” to the more comprehensive “diabetes care and education specialist.” The new title more accurately signifies the range of expertise diabetes care and education specialists provide to people with diabetes, prediabetes and cardiometabolic conditions, the health care system, payers and providers.
“The ADCES name and specialty title integrate…
moreThe AACE diabetes algorithm is a comprehensive management algorithm that covers lifestyle, obesity, prediabetes, lipids, hypertension and glucose management strategies. It is the most up-to-date and progressive management algorithm that now includes strategies based on all the newest cardiovascular (CV) outcome trials in diabetes and related metabolic CV outcome trials and incorporates the latest FDA indications.
Strategies included in the 2020 AACE diabetes algorithm go beyond just managing and controlling CV risk factors to preventing the next CV events - morbidity and mortality in both…
moreMedtronic has recalled its MiniMed Insulin Pumps for incorrect insulin dosing. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
Recalled Product
- MiniMed 600 Series Insulin Pumps
- Model 630G (MMT-1715) - all lots before October 2019
- Model 670G (MMT-1780) - all lots before August 2019
- Distribution Dates
- Model 630G - September 2016 to October 2019
- Model 670G - June 2017 to August 2019
- Devices Recalled in the U.S…
moreFOUNDERS SOCIETY
Founders Society are those donors who have given $10,000 or above as a one-time gift, pledge or cumulative.
Abbvie Inc
Ascensia
AstraZeneca
Bristol-Myers Squibb Company
California Chapter of AACE
Dexcom, Inc.
Dr. Daniel Einhorn
Dr. Jeffrey R. Garber
Dr. Claudia Graham
Dr. Carlos R. Hamilton, Jr.
Dr. Yehuda Handelsman
Dr. Stephen F. Hodgson
Dr. Bill Law, Jr.
Dr. Anne L. Leddy
Lilly
Dr. Jeffrey I. Mechanick
Mr. Frank H. Meggers
Nevada Chapter of AACE
Pacific Northwest Chapter of AACE
R…
moreDue to signals in safety clinical trials showing possible increased risk of cancer, The U.S. Food and Drug Administration (FDA) requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market. The drug manufacturer, Eisai Inc, has submitted a request to voluntarily withdraw the drug and Eisai Inc. announced that it will comply with voluntarily withdrawing Belviq from the market and discontinuing sales in the U.S.
The safety signal arose from analysis of CAMELLA-TIMI 61, a randomized,…
moreAACE's education programs are one of the most important benefits for its members. For this reason, AACE has updated the AACE Learning Center, to incorporate better functionality, enhanced support and new learning opportunities.
AACE is excited to share all the benefits of this improved system with you. Below, read in-depth instructions on accessing the AACE Learning Center and its helpful features.
AACE Learning Center Walkthrough
RUNTIME: 2:25
Watch to see all the benefits of the improved AACE Learning Center.
-->
How to Access the AACE Learning Center…
moreCoinciding with World Obesity Day, AACE has joined over 100 medical and scientific organizations across the world in pledging our support for a consensus statement that recognizes unscientific public narratives of obesity as a major cause of weight stigma and calls for strong policies and legislation to prevent weight-based discrimination.
In a paper published today in Nature Medicine, a team of experts, led by Professor Francesco Rubino from King’s College London, outline a joint international consensus statement and a related Pledge to Eradicate Weight Stigma. The statement was developed…
moreThe global Novel Coronavirus COVID-19 has continued to spread to areas of the world beyond China with an accelerating and unpredictable trajectory. Per the World Health Organization (WHO), this threat will likely grow. The Centers for Disease Control and Prevention (CDC) announced that the virus is expected to impact the United States in a more severe way than it has to date, although when and to what degree is still unknown.
Our first priority—now and always—is the health and safety of our staff and members. AACE is closely monitoring the information being shared about the virus and will…
moreAs the coronavirus (COVID-19) continues to spread in the United States, it is important for everyone to take the necessary precautions to help prevent infection and spread of the virus. While it is difficult to assess the unique implications of COVID-19 in people with diabetes (type 1, type 2, or gestational) at this time, diabetes and other chronic medical conditions can make patients more vulnerable to infections, leading to serious consequences. In addition, uncontrolled diabetes with hyperglycemia is known to impair immune function. Because patients with diabetes may also have many other…
moreIn an effort to limit the spread of the coronavirus, the Trump Administration announced today that it is expanding Medicare telehealth coverage so that beneficiaries can receive healthcare services without having to travel to their physician's office. Beginning on March 6, 2020, Medicare will temporarily pay clinicians to provide telehealth services for beneficiaries across the entire country. Beneficiaries will be able to receive telehealth services in any healthcare facility including a physician's office, hospital, nursing home or rural health clinic, as well as from their homes.
The…
more
